1. Home
  2. EVOK vs OMH Comparison

EVOK vs OMH Comparison

Compare EVOK & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • OMH
  • Stock Information
  • Founded
  • EVOK 2007
  • OMH 2015
  • Country
  • EVOK United States
  • OMH Singapore
  • Employees
  • EVOK N/A
  • OMH N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • OMH Real Estate
  • Sector
  • EVOK Health Care
  • OMH Finance
  • Exchange
  • EVOK Nasdaq
  • OMH Nasdaq
  • Market Cap
  • EVOK 7.1M
  • OMH 8.0M
  • IPO Year
  • EVOK 2013
  • OMH 2023
  • Fundamental
  • Price
  • EVOK $4.99
  • OMH $0.38
  • Analyst Decision
  • EVOK
  • OMH Strong Buy
  • Analyst Count
  • EVOK 0
  • OMH 1
  • Target Price
  • EVOK N/A
  • OMH $1.50
  • AVG Volume (30 Days)
  • EVOK 9.5K
  • OMH 82.9K
  • Earning Date
  • EVOK 03-13-2025
  • OMH 09-25-2024
  • Dividend Yield
  • EVOK N/A
  • OMH N/A
  • EPS Growth
  • EVOK N/A
  • OMH N/A
  • EPS
  • EVOK N/A
  • OMH N/A
  • Revenue
  • EVOK $8,617,036.00
  • OMH $5,390,607.00
  • Revenue This Year
  • EVOK $97.35
  • OMH $101.90
  • Revenue Next Year
  • EVOK $99.52
  • OMH $38.34
  • P/E Ratio
  • EVOK N/A
  • OMH N/A
  • Revenue Growth
  • EVOK 100.35
  • OMH 25.77
  • 52 Week Low
  • EVOK $3.54
  • OMH $0.32
  • 52 Week High
  • EVOK $12.32
  • OMH $1.62
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 58.60
  • OMH 53.13
  • Support Level
  • EVOK $4.68
  • OMH $0.33
  • Resistance Level
  • EVOK $5.19
  • OMH $0.37
  • Average True Range (ATR)
  • EVOK 0.31
  • OMH 0.02
  • MACD
  • EVOK 0.03
  • OMH 0.00
  • Stochastic Oscillator
  • EVOK 72.64
  • OMH 100.00

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, Property Management Services, and revenue from emerging and other services.

Share on Social Networks: